Former Biogen Chief Executive Officer James C. Mullen has leapt from his leadership role at Patheon N.V., a pharmaceutical contract development and manufacturing organization, to take the helm at genome editing company Editas Medicine.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,